Literature DB >> 7213409

Meanings of Ki for conventional and alternate-substrate inhibitors.

T Spector, W W Cleland.   

Abstract

Mesh：

Substances：

Year:  1981        PMID： 7213409     DOI： 10.1016/0006-2952(81)90277-x

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN： 0006-2952            Impact factor:   5.858


× No keyword cloud information.
  7 in total

1.  6-Methoxypurine arabinoside as a selective and potent inhibitor of varicella-zoster virus.

Authors:  D R Averett; G W Koszalka; J A Fyfe; G B Roberts; D J Purifoy; T A Krenitsky
Journal:  Antimicrob Agents Chemother       Date:  1991-05       Impact factor: 5.191

Review 2.  Metabolism of drugs by cytochrome P450 3A isoforms. Implications for drug interactions in psychopharmacology.

Authors:  L L von Moltke; D J Greenblatt; J Schmider; J S Harmatz; R I Shader
Journal:  Clin Pharmacokinet       Date:  1995       Impact factor: 6.447

3.  Mutant varicella-zoster virus thymidine kinase: correlation of clinical resistance and enzyme impairment.

Authors:  G B Roberts; J A Fyfe; R K Gaillard; S A Short
Journal:  J Virol       Date:  1991-12       Impact factor: 5.103

4.  A mechanism for posttranslational modifications of proteins by yeast protein farnesyltransferase.

Authors:  J M Dolence; C D Poulter
Journal:  Proc Natl Acad Sci U S A       Date:  1995-05-23       Impact factor: 11.205

5.  Reactive thioglucoside substrates for β-glucosidase.

Authors:  Elizabeth Alverson-Banks Avegno; Scott J Hasty; Archana R Parameswar; Gary S Howarth; Alexei V Demchenko; Larry D Byers
Journal:  Arch Biochem Biophys       Date:  2013-06-27       Impact factor: 4.013

6.  5-Chloro-2',3'-dideoxy-3'-fluorouridine (935U83), a selective anti-human immunodeficiency virus agent with an improved metabolic and toxicological profile.

Authors:  S M Daluge; D J Purifoy; P M Savina; M H St Clair; N R Parry; I K Dev; P Novak; K M Ayers; J E Reardon; G B Roberts
Journal:  Antimicrob Agents Chemother       Date:  1994-07       Impact factor: 5.191

7.  Mode of action of (R)-9-[4-hydroxy-2-(hydroxymethyl)butyl]guanine against herpesviruses.

Authors:  D M Lowe; W K Alderton; M R Ellis; V Parmar; W H Miller; G B Roberts; J A Fyfe; R Gaillard; P Ertl; W Snowden
Journal:  Antimicrob Agents Chemother       Date:  1995-08       Impact factor: 5.191
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.